When patient and insurer spending on GLP-1s jumped from $13.7 billion in 2018 to $71.7 billion in 2023, the financial surge drew headlines that framed the increase in consumption as innovation rather than as expanded access to an existing treatment
One reason BPC-157 gets so much attention is that it appears in research across several tissue categories rather than just one
"It inaccurately labels people and it actually leads to people engaging less with their health." It's important to recognize that health and fitness looks like a million different things, and not just one specific body type (as Maher so beautifully explained)
Metabolism 62(12):17181729 Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B (2015) Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults
Researchers seeking the authorized drug for any clinical purpose should consult a licensed Canadian prescriber
A fill-in tracker to measure your progress and see the changes in your strength